Practice of pharmacy; allowing pharmacist to test or screen for and initiate drug therapy under certain circumstances; specifying allowed tests; modifying and adding certain definitions. Effective date. Emergency.
Impact
If enacted, SB931 would significantly reshape aspects of the practice of pharmacy in Oklahoma. The bill allows pharmacists to perform clinical screenings that were previously restricted to licensed medical practitioners, enabling them to address specific health issues, such as influenza or other minor ailments, more effectively. This change is expected to enhance public health outcomes by providing patients with more immediate care options in community pharmacies and could potentially reduce the strain on healthcare facilities for minor health concerns.
Summary
Senate Bill 931 aims to enhance the role of pharmacists in managing minor, nonchronic health conditions by allowing them to screen for and initiate drug therapy. This legislation specifies the types of tests that can be utilized by pharmacists and includes provisions for the dispensing of self-administered hormonal contraceptives without the necessity for a prescription. By modifying existing definitions within the Oklahoma Pharmacy Act, the bill intends to expand the pharmacy practice scope, thereby improving accessibility to healthcare and easing the burden on primary care providers.
Sentiment
The reception of SB931 appears to be largely supportive among stakeholders who advocate for expanded pharmacist roles in patient care. Proponents argue that the bill would facilitate more efficient healthcare delivery and improve patient access to necessary treatments. However, there may be concerns regarding the training and oversight of pharmacists in conducting health screenings and initiating treatments, indicating a need for well-defined protocols to ensure patient safety and the effectiveness of care.
Contention
Notable points of contention regarding SB931 may arise from the implications of pharmacists' involvement in drug therapy initiation, particularly with hormonal contraceptives. While some legislators and health advocates support these capabilities for enhancing pharmacy services, there could be pushback from factions emphasizing the necessity of continuous medical oversight for drug therapy initiation, arguing that such responsibilities should remain exclusively with traditional healthcare providers. This reflects a broader debate surrounding the evolution of pharmacy practice and its integration into the healthcare system.
Pharmacy benefit managers; modifying definitions; prohibiting certain circumstances; requiring nonpayment under providing venue for certain court proceeding; allowing Attorney General to obtain certain information. Effective date.
Pharmacy benefit managers; modifying definitions; prohibiting certain circumstances; requiring nonpayment under providing venue for certain court proceeding; allowing Attorney General to obtain certain information. Effective date.
Permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience, adding pharmacists who initiate such therapy to the healthcare stabilization fund and allowing a pharmacist to dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain.
Establishing the remote practice of pharmacy, requiring certain conditions for such practice and limiting activities performed under such practice, permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience, adding pharmacists who initiate such therapy to the healthcare stabilization fund and allowing a pharmacist to dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain, adopting compounding standards established by the United States pharmacopeia and allowing for exemptions from such standards and removing the authority of the state board of pharmacy to authorize individuals to access the prescription monitoring program database by rules and regulations.
Practice of pharmacy; authorizing pharmacists to dispense certain medication upon certain federal approval and subject to certain conditions. Effective date.
Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.
Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.